- Home
- CHD vs LSBPW Comparison
CHD vs LSBPW Comparison
Compare CHD & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHD
- LSBPW
- Stock Information
- Founded
- CHD 1846
- LSBPW N/A
- Country
- CHD United States
- LSBPW China
- Employees
- CHD N/A
- LSBPW 758
- Industry
- CHD Package Goods/Cosmetics
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- CHD Consumer Discretionary
- LSBPW Health Care
- Exchange
- CHD Nasdaq
- LSBPW Nasdaq
- Market Cap
- CHD N/A
- LSBPW N/A
- IPO Year
- CHD N/A
- LSBPW N/A
- Fundamental
- Price
- CHD $109.96
- LSBPW $0.04
- Analyst Decision
- CHD Buy
- LSBPW
- Analyst Count
- CHD 19
- LSBPW 0
- Target Price
- CHD $108.53
- LSBPW N/A
- AVG Volume (30 Days)
- CHD 1.6M
- LSBPW N/A
- Earning Date
- CHD 11-01-2024
- LSBPW N/A
- Dividend Yield
- CHD 1.03%
- LSBPW N/A
- EPS Growth
- CHD 26.23
- LSBPW N/A
- EPS
- CHD 2.23
- LSBPW N/A
- Revenue
- CHD $6,053,100,000.00
- LSBPW N/A
- Revenue This Year
- CHD $4.81
- LSBPW N/A
- Revenue Next Year
- CHD $3.93
- LSBPW N/A
- P/E Ratio
- CHD $49.32
- LSBPW N/A
- Revenue Growth
- CHD 4.80
- LSBPW N/A
- 52 Week Low
- CHD $90.26
- LSBPW N/A
- 52 Week High
- CHD $113.50
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- CHD 58.87
- LSBPW N/A
- Support Level
- CHD $109.35
- LSBPW N/A
- Resistance Level
- CHD $113.44
- LSBPW N/A
- Average True Range (ATR)
- CHD 1.92
- LSBPW 0.00
- MACD
- CHD -0.10
- LSBPW 0.00
- Stochastic Oscillator
- CHD 48.47
- LSBPW 0.00
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.